Primary hyperparathyroidism across the care continuum: gaps in diagnosis, access to surgery, and post-operative care

Abstract Background PHPT (primary hyperparathyroidism) is a common endocrine disorder characterised by inappropriate elevation of parathyroid hormone (PTH) and hypercalcaemia, leading to multisystem complications, including skeletal fragility, nephrolithiasis, neurocognitive impairment, and cardiovascular risks. Despite the availability of curative parathyroidectomy (surgical removal of overactive parathyroid gland(s)), many patients experience delayed diagnosis and inequitable access to surgery. Main text Diagnostic delay in PHPT is driven by inconsistent application of testing guidelines, limited use of ionised calcium, biochemical masking by vitamin D deficiency, age-related diagnostic ambiguity, patient and clinician unawareness of the condition, and reliance on fixed calcium thresholds, resulting in frequent incidental diagnosis and a substantial proportion of patients remaining undiagnosed despite biochemical evidence. Surgical referral is often restricted by arbitrary serum calcium cut-offs and age-based differential criteria, even though evidence demonstrates that timely surgery improves outcomes across age groups. Recognition of PHPT as a systemic disorder extending beyond classical skeletal and renal manifestations highlights the need to consider its broader clinical spectrum, including neurocognitive symptoms and other potential systemic manifestations. Postoperative care remains insufficiently addressed, yet persistent and recurrent PHP require long-term biochemical monitoring, and skeletal recovery require structured follow-up. Conclusions Timely recognition of PHPT and equitable access to curative parathyroidectomy are essential to reduce disease burden and prevent avoidable morbidity. Greater clinical awareness of the broader clinical spectrum of PHPT, improved diagnostic and referral pathways, and stronger evidence on disease trajectories, treatment response, and long-term follow-up are needed to address persistent gaps across the PHPT care continuum.

Authors

Institutions

Publication Details

Journal
BMC Medicine
Published
2026-10-22
DOI
https://doi.org/10.1186/s12916-026-05297-7
Primary Topic
Parathyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Primary hyperparathyroidism across the care continuum: gaps in diagnosis, access to surgery, and post-operative care

Hortense Wilmot-Roussel, Sonia Menon, Shahab Khan, Natasha Zdraveska et al.
BMC Medicine
Parathyroid Disorders and Treatments
article

Primary hyperparathyroidism across the care continuum: gaps in diagnosis, access to surgery, and post-operative care

Hortense Wilmot-Roussel, Sonia Menon, Shahab Khan, Natasha Zdraveska, Alison Waghorn
article en

Abstract

Abstract Background PHPT (primary hyperparathyroidism) is a common endocrine disorder characterised by inappropriate elevation of parathyroid hormone (PTH) and hypercalcaemia, leading to multisystem complications, including skeletal fragility, nephrolithiasis, neurocognitive impairment, and cardiovascular risks. Despite the availability of curative parathyroidectomy (surgical removal of overactive parathyroid gland(s)), many patients experience delayed diagnosis and inequitable access to surgery. Main text Diagnostic delay in PHPT is driven by inconsistent application of testing guidelines, limited use of ionised calcium, biochemical masking by vitamin D deficiency, age-related diagnostic ambiguity, patient and clinician unawareness of the condition, and reliance on fixed calcium thresholds, resulting in frequent incidental diagnosis and a substantial proportion of patients remaining undiagnosed despite biochemical evidence. Surgical referral is often restricted by arbitrary serum calcium cut-offs and age-based differential criteria, even though evidence demonstrates that timely surgery improves outcomes across age groups. Recognition of PHPT as a systemic disorder extending beyond classical skeletal and renal manifestations highlights the need to consider its broader clinical spectrum, including neurocognitive symptoms and other potential systemic manifestations. Postoperative care remains insufficiently addressed, yet persistent and recurrent PHP require long-term biochemical monitoring, and skeletal recovery require structured follow-up. Conclusions Timely recognition of PHPT and equitable access to curative parathyroidectomy are essential to reduce disease burden and prevent avoidable morbidity. Greater clinical awareness of the broader clinical spectrum of PHPT, improved diagnostic and referral pathways, and stronger evidence on disease trajectories, treatment response, and long-term follow-up are needed to address persistent gaps across the PHPT care continuum.

BMC Medicine
Hôpital américain de paris (FR), University of Liverpool (GB), Copenhagen University Hospital (DK), Rigshospitalet (DK), Royal Liverpool University Hospital (GB), University of Oxford (GB), Oxford University Hospitals NHS Trust (GB)
Openalex Percentile: Top 12%
Parathyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon